Primary Sclerosing Cholangitis clinical trials

Explore recruiting primary sclerosing cholangitis clinical trials.

Recruiting primary sclerosing cholangitis studies right now

Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Primary Sclerosing Cholangitis trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

Pyridoxine in primary sclerosing cholangitis

Norway

Therapeutic exploratory (Phase II) EU CTIS Study details

A Prospective, Randomized, Placebo-controlled Clinical Trial of oral vancomycin in adults and young adults (15-17 years old) affected by Primary Sclerosing Cholangitis with or without Inflammatory Bowel Disease

Italy

Therapeutic exploratory (Phase II) EU CTIS Study details

A Phase II, Multicenter, Double-Blind, Randomised, Placebo-Controlled Study and Open-Label Long Term Extension to Evaluate the Safety and Efficacy of Elafibranor in Adult Participants with Primary Sclerosing Cholangitis (PSC)

Spain, Italy, Germany, Portugal

Therapeutic exploratory (Phase II) EU CTIS Study details

An Open-label study of patients with primary sclerosing cholangitis (PSC) treated with norucholic acid tablets

Germany, Netherlands, Belgium, France, Norway, Austria +4 more

Therapeutic confirmatory (Phase III) EU CTIS Study details

A Mass Balance Study of [14C]-IPN60250 in Healthy Adult Participants

Netherlands

Human Pharmacology (Phase I)- Other EU CTIS Study details

A Phase III, Multicentre, Randomised, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Elafibranor in Adult Participants with Primary Sclerosing Cholangitis

Austria

Therapeutic confirmatory (Phase III) EU CTIS Study details

Primary Sclerosing Cholangitis trials by city

Primary Sclerosing Cholangitis in Toronto Primary Sclerosing Cholangitis in Vancouver Primary Sclerosing Cholangitis in Montreal Primary Sclerosing Cholangitis in Calgary Primary Sclerosing Cholangitis in Edmonton Primary Sclerosing Cholangitis in Ottawa Primary Sclerosing Cholangitis in Winnipeg Primary Sclerosing Cholangitis in Quebec City Primary Sclerosing Cholangitis in Hamilton Primary Sclerosing Cholangitis in Kitchener Primary Sclerosing Cholangitis in London Primary Sclerosing Cholangitis in Halifax Primary Sclerosing Cholangitis in New York Primary Sclerosing Cholangitis in Los Angeles Primary Sclerosing Cholangitis in Chicago Primary Sclerosing Cholangitis in Houston

Other conditions

Obesity Type 2 diabetes Type 1 diabetes Prediabetes Weight loss Metabolic syndrome High cholesterol High triglycerides High blood pressure PCOS Hypothyroidism Thyroid disease Gout Fatty liver disease (NAFLD/NASH) Heart failure Coronary artery disease Atrial fibrillation Stroke Stroke recovery Peripheral artery disease Pulmonary hypertension Deep vein thrombosis Chronic kidney disease Diabetic kidney disease